Brief: Microport Scientific Posts Qtrly Net Profit Attributable Of Shanghai Microport Endovascular Medtech RMB123.5 Mln
29/04/2022 14:42
April 29 (Reuters) - Microport Scientific Corp 0853.HK :
* QTRLY NET PROFIT ATTRIBUTABLE OF SHANGHAI MICROPORT
ENDOVASCULAR
MEDTECH RMB123.5 MILLION, UP 21.44%
* QTRLY REVENUE FOR SHANGHAI MICROPORT ENDOVASCULAR MEDTECH
RMB
257.9 MILLION, UP 30.59%
Source text for Eikon: ID:nHKS71qS5D
Further company coverage: 0853.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on MicroPort Scientific
See all newsBrief: Microport Scientific Says Delay In Publication Of Interim Results
Brief: Microport Scientific Announces Delay In Publication Of 2026 Interim Results
Brief: Microport Scientific Says Shanghai Microport Endovascular Medtech Logs HY Revenue Of RMB793.95 Million
Brief: Microport Scientific Sees 12%-14% Y/Y Revenue Growth In Continuing Operations For HY
Brief: Microport Scientific Unit And Others To Sell 62% Of Shanghai Microport Orthopedics To Tinavi